422 related articles for article (PubMed ID: 35453377)
1. Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer's Disease.
Onukwufor JO; Dirksen RT; Wojtovich AP
Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453377
[TBL] [Abstract][Full Text] [Related]
2. The key roles of organelles and ferroptosis in Alzheimer's disease.
Long HZ; Cheng Y; Zhou ZW; Luo HY; Wen DD; Gao LC
J Neurosci Res; 2022 Jun; 100(6):1257-1280. PubMed ID: 35293012
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.
Wang M; Tang G; Zhou C; Guo H; Hu Z; Hu Q; Li G
Chem Biol Interact; 2023 Apr; 375():110387. PubMed ID: 36758888
[TBL] [Abstract][Full Text] [Related]
4. The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer's Disease: from the Perspective of Ferroptosis.
Wu L; Xian X; Tan Z; Dong F; Xu G; Zhang M; Zhang F
Mol Neurobiol; 2023 May; 60(5):2832-2850. PubMed ID: 36735178
[TBL] [Abstract][Full Text] [Related]
5. Penthorum chinense Pursh inhibits ferroptosis in cellular and Caenorhabditis elegans models of Alzheimer's disease.
Yong YY; Yan L; Wang BD; Fan DS; Guo MS; Yu L; Wu JM; Qin DL; Law BY; Wong VK; Yu CL; Zhou XG; Wu AG
Phytomedicine; 2024 May; 127():155463. PubMed ID: 38452694
[TBL] [Abstract][Full Text] [Related]
6. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
7. Noxious Iron-Calcium Connections in Neurodegeneration.
Núñez MT; Hidalgo C
Front Neurosci; 2019; 13():48. PubMed ID: 30809110
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis, a Potential Therapeutic Target in Alzheimer's Disease.
Chen K; Jiang X; Wu M; Cao X; Bao W; Zhu LQ
Front Cell Dev Biol; 2021; 9():704298. PubMed ID: 34422824
[TBL] [Abstract][Full Text] [Related]
9. Iron Dyshomeostasis and Ferroptosis: A New Alzheimer's Disease Hypothesis?
Wang F; Wang J; Shen Y; Li H; Rausch WD; Huang X
Front Aging Neurosci; 2022; 14():830569. PubMed ID: 35391749
[TBL] [Abstract][Full Text] [Related]
10. Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia.
Cerasuolo M; Di Meo I; Auriemma MC; Trojsi F; Maiorino MI; Cirillo M; Esposito F; Polito R; Colangelo AM; Paolisso G; Papa M; Rizzo MR
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298586
[TBL] [Abstract][Full Text] [Related]
11. VDAC1, mitochondrial dysfunction, and Alzheimer's disease.
Shoshan-Barmatz V; Nahon-Crystal E; Shteinfer-Kuzmine A; Gupta R
Pharmacol Res; 2018 May; 131():87-101. PubMed ID: 29551631
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review.
Zhao D; Yang K; Guo H; Zeng J; Wang S; Xu H; Ge A; Zeng L; Chen S; Ge J
Biomed Pharmacother; 2023 Aug; 164():114312. PubMed ID: 37210894
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis: A new strategy for targeting Alzheimer's disease.
Qiang RR; Xiang Y; Zhang L; Bai XY; Zhang D; Li YJ; Yang YL; Liu XL
Neurochem Int; 2024 May; 178():105773. PubMed ID: 38789042
[TBL] [Abstract][Full Text] [Related]
14. NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases.
Park MW; Cha HW; Kim J; Kim JH; Yang H; Yoon S; Boonpraman N; Yi SS; Yoo ID; Moon JS
Redox Biol; 2021 May; 41():101947. PubMed ID: 33774476
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders.
Mena NP; Urrutia PJ; Lourido F; Carrasco CM; Núñez MT
Mitochondrion; 2015 Mar; 21():92-105. PubMed ID: 25667951
[TBL] [Abstract][Full Text] [Related]
16. Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer's disease: Evidence of ferroptosis.
Ashraf A; Jeandriens J; Parkes HG; So PW
Redox Biol; 2020 May; 32():101494. PubMed ID: 32199332
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis Is Regulated by Mitochondria in Neurodegenerative Diseases.
Zhou J; Jin Y; Lei Y; Liu T; Wan Z; Meng H; Wang H
Neurodegener Dis; 2020; 20(1):20-34. PubMed ID: 32814328
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
[TBL] [Abstract][Full Text] [Related]
19. The Potential of Ferroptosis-Targeting Therapies for Alzheimer's Disease: From Mechanism to Transcriptomic Analysis.
Majerníková N; den Dunnen WFA; Dolga AM
Front Aging Neurosci; 2021; 13():745046. PubMed ID: 34987375
[TBL] [Abstract][Full Text] [Related]
20. Iron dyshomeostasis and ferroptosis in Alzheimer's disease: Molecular mechanisms of cell death and novel therapeutic drugs and targets for AD.
Zhang Y; Wang M; Chang W
Front Pharmacol; 2022; 13():983623. PubMed ID: 36188557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
